| Colleen Christina Kniffin, MD | |
|
1035 116th Ave Ne, Overlake Hospital Medical Center, Bellevue, WA 98004 | |
| (425) 688-5100 | |
| Not Available |
| Full Name | Colleen Christina Kniffin |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 1035 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952565269 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Peacehealth Peace Island Medical Center | Friday harbor, WA | Hospital |
| Snoqualmie Valley Hospital | Snoqualmie, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Puget Sound Physicians Pllc | 2961301882 | 24 |
News Archive
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
› Verified 3 days ago
| Entity Name | Puget Sound Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801900501 PECOS PAC ID: 2961301882 Enrollment ID: O20040108000594 |
News Archive
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
› Verified 3 days ago
| Entity Name | Public Hospital District No 4 King County Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902846546 PECOS PAC ID: 6002700861 Enrollment ID: O20040211001236 |
News Archive
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
› Verified 3 days ago
| Entity Name | Peacehealth Peace Island Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508129842 PECOS PAC ID: 9335391044 Enrollment ID: O20130122000273 |
News Archive
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Christina Kniffin, MD 1035 116th Ave Ne, Pugel Sound Physicians, Bellevue, WA 98004 Ph: (612) 750-9740 | Colleen Christina Kniffin, MD 1035 116th Ave Ne, Overlake Hospital Medical Center, Bellevue, WA 98004 Ph: (425) 688-5100 |
News Archive
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
› Verified 3 days ago
Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640 | |
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515 | |
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 | |
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 |